Healthcare -
Biotechnology - NASDAQ - US
$ 4.8325
124 %
$ 15 M
Market Cap
-0.15
P/E
BTAI - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities BTAI - BioXcel Therapeutics, Inc.
26.5 M
LAST VALUE
-49.12%
2 YEAR CAGR
-13.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR